Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Venous Thromboembolism
Interventions
DRUG

dalteparin

dalteparin subcutaneous injection

Trial Locations (26)

20007

MedStar Georgetown University Hospital, Washington D.C.

28660

Hospital HM Universitario Monteprincipe Servicio de Farmacia, Boadilla del Monte

Hospital HM Universitario Monteprincipe, Boadilla del Monte

32207

Nemours Children's Clinic, Jacksonville

Wolfson Children's Hospital, Jacksonville

33606

Investigational Drug Service Tampa General Hospital, Tampa

Tampa General Hospital Center of Research Excellence, Tampa

Tampa General Hospital, Tampa

University of South Florida, Tampa

33607

St. Joseph's Children's Hospital of Tampa, Tampa

38105

St. Jude Children's Research Hospital, Memphis

48201

Children's Hospital of Michigan, Detroit

64108

Children's Mercy Hospitals and Clinics, Kansas City

77030

Texas Children's Cancer and Hematology Centers, Houston

Texas Children's Hospital Investigational Pharmacy Services, Houston

Texas Children's Hospital, Houston

79905

El Paso Children's Hospital, El Paso

Texas Tech University Health Sciences Center El Paso, El Paso

80045

Children's Hospital Colorado, Aurora

119049

SBHI of Moscow city Morozovskaya Children City Clinical Hospital of Moscow city, Moscow

420012

FSBEI HE Kazan SMU of Minzdrav Russia, Kazan'

420138

"SAHI Children's Republican Clinical Hospital of the Ministry of", Kazan'

0372

Sykehusapoteket Oslo, Oslo

0424

Oslo universitetssykehus HF, Oslo

SI-1000

Lekarna, Univerzitetni klinicni center Ljubljana, Ljubljana

Pediatricna klinika, Univerzitetni Klinicni Center Ljubljana, Ljubljana

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY